What happens when elite endurance training, wearable data, artificial intelligence, and peptide therapy collide? In this episode of the Innovation Storytellers Show, I sat down with Tony Medrano, CEO and co-founder of LongevityPlan.AI, to unpack how the future of longevity is being shaped by technology that once felt more science fiction than healthcare strategy.
Tony’s journey alone feels like a case study in reinvention. A former naval officer, Stanford entrepreneur, AI startup founder, and three-time Ironman triathlete, he has spent decades building companies around emerging technologies long before the market was ready for them. From helping shape the early mobile app ecosystem before smartphones even existed to working with organizations like NASA, the NFL, and Google on AI and molecular diagnostics, Tony has repeatedly found himself at the edge of major technology shifts.
But this conversation quickly moved beyond startup stories and venture capital war stories. We explored how peptide therapies are being used to support recovery, performance optimization, injury repair, and preventative health, particularly as people search for ways to extend not just lifespan, but healthspan. Tony explained how LongevityPlan.AI combines wearable technology, biomarker analysis, AI-powered digital twins, and physician-guided peptide programs to create personalized health optimization plans.
What made this discussion especially fascinating was the tension between innovation and evidence. Tony openly acknowledged that peptide therapies still sit in a space where anecdotal results, emerging science, and limited large-scale clinical trials coexist. That creates both excitement and skepticism. For some, this represents the future of preventative healthcare and human optimization. For others, it raises questions about regulation, accessibility, affordability, and where the line exists between wellness enhancement and medical intervention.
We also discussed how longevity itself is becoming one of the defining themes across industries. Whether it’s financial services rebranding retirement planning, manufacturers extending the lifecycle of industrial systems, or healthcare companies focusing on prevention over treatment, the concept of optimizing long-term performance is reshaping the conversation everywhere.
Along the way, Tony reflected on surviving the dot-com crash, raising millions before product launch, training for Ironman races while recovering from serious injuries, and why he believes the future of healthcare belongs to people who take a more active role in understanding their own bodies and data.
This episode is a conversation about far more than fitness or supplements. It’s about the growing convergence of AI, biotechnology, consumer health, performance culture, and human ambition. And perhaps most importantly, it asks a bigger question: if technology can help us live longer, healthier lives, how do we ensure we use it responsibly, ethically, and in ways that genuinely improve the human experience?
Name: Tony Medrano
Title: CEO & Co-Founder
Company: LongevityPlan.AI
LinkedIn | LongevityPlan.AI Website |
Tony Medrano is CEO and co-founder of LongevityPlan.AI, a platform that integrates performance and health data from athletes and leverages proprietary Digital Twin for Predictive Peptide Performance™ technology, wearable data, and biomarker data to deliver personalized performance optimization and longevity recommendations to athletes, coaches, organizations, businesses, government, and the military. In addition to being a 3x technology / AI company CEO with 2 successful exits, Tony has also finished 3 Full Ironman Triathlons (140.6 mi) since 2019.
My guest has degrees from Harvard University,Columbia University, and a JD/MBA fromStanford University. Tony has been involved with AI and molecular diagnostic start-ups for 10 years, and also worked with the US Olympic Team,National Basketball Association (NBA),National Football League (NFL),Major League Baseball (MLB),Iditarod, FBI, NASA, U.S. Department of Health and Human Services (HHS),Google,Microsoft,Netflix,Bridgewater Associates,ConocoPhillips, British Petroleum, One Medical, and Jenny Craig, Inc. to provide technology, artificial intelligence and/or molecular diagnostics solutions to their employees.
One of Tony’s prior companies provided Conversational AI to health, fitness, and wellness companies; another delivered access to digital libraries of British Petroleum for oil discovery; and his first was a mobile app platform funded by Softbank, which resulted in a case study published byStanford University Press, and was taught in multiple MBA programs for a decade.
Tony loves to teach and mentor; he earned public school teaching credentials in NY and MA and taught inner-city high school students to give back to the underprivileged community in Harlem. He also lectured on entrepreneurship and venture capital to second-year MBA students at Stanford Business School for five years. He co-authored one of thefirst issued patents for mobile applications.
Tony also served as aUS Navy Officer commanding an emergency response team on a USN Destroyer. Tony’s military-to-CEO career has recently been chosen to air on an episode of “Operation CEO” a documentary byInsideSuccess.TV, which will air on AppleTV,Prime Video & Amazon MGM Studios, YouTubeTV, and other major platforms worldwide in 2026.